A new trading day began on Monday, with Alx Oncology Holdings Inc (NASDAQ: ALXO) stock price up 13.04% from the previous day of trading, before settling in for the closing price of $1.38. ALXO’s price has ranged from $0.40 to $2.27 over the past 52 weeks.
Healthcare Sector giant saw their annual sales slid by -32.29% over the last five years. Meanwhile, its annual earnings per share averaged 29.55%. With a float of $38.21 million, this company’s outstanding shares have now reached $53.58 million.
Alx Oncology Holdings Inc (ALXO) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Alx Oncology Holdings Inc is 29.53%, while institutional ownership is 34.42%. The most recent insider transaction that took place on Sep 17 ’25, was worth 76,892. In this transaction CHIEF EXECUTIVE OFFICER of this company bought 71,163 shares at a rate of $1.08, taking the stock ownership to the 305,121 shares. Before that another transaction happened on Sep 16 ’25, when Company’s CHIEF EXECUTIVE OFFICER bought 21,070 for $1.07, making the entire transaction worth $22,461. This insider now owns 233,958 shares in total.
Alx Oncology Holdings Inc (ALXO) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.44 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 29.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.13% during the next five years compared to -32.29% drop over the previous five years of trading.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Trading Performance Indicators
Here are Alx Oncology Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.03, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.12 in one year’s time.
Technical Analysis of Alx Oncology Holdings Inc (ALXO)
Analysing the last 5-days average volume posted by the [Alx Oncology Holdings Inc, ALXO], we can find that recorded value of 0.49 million was lower than the volume posted last year of 0.79 million. As of the previous 9 days, the stock’s Stochastic %D was 57.94%.
During the past 100 days, Alx Oncology Holdings Inc’s (ALXO) raw stochastic average was set at 61.95%, which indicates a significant decrease from 85.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1767 in the past 14 days, which was higher than the 0.1251 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5248, while its 200-day Moving Average is $0.9043. Now, the first resistance to watch is $1.6867. This is followed by the second major resistance level at $1.8133. The third major resistance level sits at $1.9767. If the price goes on to break the first support level at $1.3967, it is likely to go to the next support level at $1.2333. Should the price break the second support level, the third support level stands at $1.1067.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Key Stats
With a market capitalization of 84.58 million, the company has a total of 54,218K Shares Outstanding. Currently, annual sales are 0 K while annual income is -134,850 K. The company’s previous quarter sales were 0 K while its latest quarter income was -22,140 K.
